Related Experiment Videos
Recurrent infectious diseases in human CD53 deficiency
F Mollinedo1, G Fontán, I Barasoain
1Instituto de Biología y Genética Molecular, Facultad de Medicina, CSIC-Universidad de Valladolid, Spain.
Abstract:
We report a familiar syndrome of recurrent heterogeneous infectious diseases, caused by bacteria, fungi, and viruses, which has as its only detectable defect the lack of CD53 antigen expression in neutrophils. All other assays ruled out known causes of recurrent infectious diseases due to either leukocyte adhesion or phagocytosis defects. CD53 belongs to the transmembrane-4 superfamily of proteins, which are a novel group of membrane proteins implicated in growth regulation and cell motility and possibly cell adhesion. We postulate that defects in these membrane proteins can be clinically manifested as complex recurrent infections.
Insights
Recurrent infections in a patient were linked to absent CD53 antigen on neutrophils. This finding suggests a role for CD53 in immune defense against diverse pathogens.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Recurrent infectious diseases can stem from various immune system defects.
- Leukocyte adhesion and phagocytosis deficiencies are common causes of recurrent infections.
Observation:
- A patient presented with recurrent bacterial, fungal, and viral infections.
- Neutrophils from the patient showed a complete lack of CD53 antigen expression.
- Extensive testing ruled out known causes of immunodeficiency, including leukocyte adhesion and phagocytosis defects.
Findings:
- The sole detectable defect was the absence of CD53, a transmembrane-4 superfamily protein, on neutrophils.
- CD53 is implicated in cell growth regulation, motility, and adhesion.
- This study identifies a novel link between CD53 deficiency and susceptibility to heterogeneous infections.
Implications:
- Defects in transmembrane proteins like CD53 may lead to complex recurrent infections.
- This discovery expands our understanding of primary immunodeficiencies.
- Further research into CD53's function could reveal new therapeutic targets for infectious diseases.